Blood transfusion and alloimmunization in patients with thalassemia: Multicenter study

Pediatric Hematology and Oncology

Volumn 28, Issue 6, 2011, Pages 479-485

  Azarkeivan, Azita ^a   Ansari, Shahla ^b   Ahmadi, Mohammad Hossein ^c   Hajibeigy, Bashir ^a   Maghsudlu, Mahtab ^a   Nasizadeh, Soheila ^a   Shaigan, Mojgan ^a   Toolabi, Abdolmajid ^a   Salahmand, Mitra ^a  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alloantibody; alloimmunization; antibody screening; gel method thalassemia; transfusion reaction

Indexed keywords

RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ANTIBODY SCREENING; ARTICLE; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; CHILD; FEMALE; FEVER; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHENOTYPE; PRESCHOOL CHILD; SCHOOL CHILD; THALASSEMIA;

ADOLESCENT; ADULT; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; INFANT; ISOANTIBODIES; MALE; MIDDLE AGED; THALASSEMIA;

EID: 80051993805     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.568595     Document Type: Article

References (26)

1. Rund D, Richmilewitz E. Pathophysiology of α and β thalassemia: therapeutic implication. Semin Hematol. 2001;38:343-349.
2. Oliveri N.Thalassemia; clinicalmanagment. Baillière Clin Haematol. 1998;11:147-623.
3. Wonke B. Clinicalmanagement of beta thalassemiamajor. Semin Hematol. 2001;38:350-359.
4. Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care. 2004;8(Suppl 2):S18-S23. (Pubitemid 39144724)
5. Azarkeivan A, Ahmadi MH, Hajibeigy B, et al. Evaluation of transfusion reactions in thalassemic patients refer to adult thalassemia center. J Zanjan UnivMed Sci Health Serv. 2008;16:57-65.
6. Prati D. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. Vox Sang. 2000;79:129-137.
7. Davenport RD. Pathophysiology of hemolytic transfusion reactions. Semin Hematol. 2005;42: 165-168. (Pubitemid 41019445)
8. Pineda AA, Vamvakas EC, Gorden LD. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion. 1999;39:1097-1103. (Pubitemid 29485326)
9. Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North Am. 2005;23:241-252. (Pubitemid 40744876)
10. Sadeghian MH, Keramati MR, Badiei Z, Ravarian M, Ayatollahi H, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci. 2009;3:95-98.
11. Lapierre Y, Rigal D, Adam J, et al.Thegel test: a new way to detect red cell antigen-antibody reactions. Transfusion. 1990;30:109-113. (Pubitemid 20068025)
12. Phillips PK,Whitton CM, Lavin F.The use of the antiglobulin "gel test" for antibody detection. TransfusMed. 1992;2:111-113.
13. Lehamann R, Kiefel V. Detection of red blood cell alloantibodies by gel centrifugation test. Transfus Med Hemother. 2003;30:117-122. (Pubitemid 37449315)
14. Knight RC, Poole GD. Detection of red cells antibodies: current and future techniques. Br J Biomed Sci. 1995;52:297-305. (Pubitemid 26007485)
15. Scott Y, Parker P, McArdel B, Wallis JP. Comparison of plasma and serum for antibody detection using Dia-Med microtubes. TransfusMed. 1996;6:65-67.
16. Walker RH, Lin DT, Hatrick MB. Alloimmunozation following blood transfusion. Arch Pathol Lab Med. 1989;113:254-261.
17. Rebulla P. Blood transfusion in beta thalassemiamajor. TransfusMed. 1995;5:247-258.
18. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, et al. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. Vox Sang. 1987;52:95-98. (Pubitemid 17052796)
19. Karimi M, Nikrooz P, Kashef S, et al. RBC alloimmunization in blood transfusion-dependent betathalassemia patients in southern Iran. Int J Lab Hematol. 2007;29:321-326. (Pubitemid 47373619)
20. Shamsian SH, ArzanianMT, Shamshiri A, Khojasteh O. Evaluation of alloimmunization in beta thalassemiamajor patients in one of referral centers in Iran. J Pediatr Dis. 1378;18:149-153.
21. Bahatti FA, Salamat N, Nadeem A, Shabbir N. Red cell immunization in beta thalassemia major. J Coll Physicians Surg Pak. 2004;14:657-660. (Pubitemid 40089950)
22. Bilwani F, Kakepoto GN, Adil SN, et al. Frequency of irregular red cell alloantibodies in patients with thalassemiamajor: a bicenter study. J Pak Med Assoc. 2005;55:563-565.
23. Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. TransfusMed. 2006;16:200-203.
24. Ameen R, Al-Shemmari S, Al-Humood S, et al.RBCalloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion. 2003;43:1604-1610. (Pubitemid 37371832)
25. Norol F, Najahi J, Bachir D, et al. Transfusion and alloimmunization in sickle cell anemia patients. Transfus Clin Biol. 1994;1:27-34.
26. Spanos T, Karageorga M, Ladis V, et al. Red cell alloantibodies in patientswith thalassemia. VoxSang. 1990;58:50-55. (Pubitemid 20042996)